165 related articles for article (PubMed ID: 10721786)
21. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
Kreft A; Nolde C; Büsche G; Buhr T; Kreipe H; Georgii A
Eur J Haematol; 2000 Jan; 64(1):32-41. PubMed ID: 10680703
[TBL] [Abstract][Full Text] [Related]
22. [A 53-year-old man with headache and concentration difficulties].
Vik A; Berntsen R; Isaksen V; Haug E; Hansen JB
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2647-9. PubMed ID: 16231451
[TBL] [Abstract][Full Text] [Related]
23. [Efficacious treatment of a fatal blood disease: polycythemia vera].
Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
[No Abstract] [Full Text] [Related]
24. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
25. [Essential thrombocythemia: conventional therapy].
Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
[No Abstract] [Full Text] [Related]
26. New Therapeutic Approaches in Polycythemia Vera.
Falchi L; Newberry KJ; Verstovsek S
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl(0):S27-33. PubMed ID: 26297275
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera.
Hess G; Rose P; Gamm H; Papadileris S; Huber C; Seliger B
Br J Haematol; 1994 Dec; 88(4):794-802. PubMed ID: 7819104
[TBL] [Abstract][Full Text] [Related]
28. How to manage polycythemia vera.
Passamonti F
Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
[TBL] [Abstract][Full Text] [Related]
29. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
30. Leukemic transformation in polycythemia vera: analysis of risk factors.
Nand S; Messmore H; Fisher SG; Bird ML; Schulz W; Fisher RI
Am J Hematol; 1990 May; 34(1):32-6. PubMed ID: 2327402
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients.
Herishanu Y; Lishner M; Bomstein Y; Kitay-Cohen Y; Fejgin MD; Gaber E; Amiel A
Cancer Genet Cytogenet; 2001 Jul; 128(2):154-7. PubMed ID: 11463455
[TBL] [Abstract][Full Text] [Related]
32. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
33. The measurement of venous haematocrit in patients with polycythaemia vera.
Andréasson B; Wahlström E; Jacobsson S; Björkholm M; Samuelsson J; Birgegård G; Wadenvik H; Kutti J
J Intern Med; 1999 Sep; 246(3):293-7. PubMed ID: 10475997
[TBL] [Abstract][Full Text] [Related]
34. Serum erythropoietin and hemoglobin affinity for oxygen in patients phlebotomized for polycythemia vera.
Cohen RA; Clemons G; Ebbe S
Adv Exp Med Biol; 1989; 271():9-15. PubMed ID: 2486292
[TBL] [Abstract][Full Text] [Related]
35. Serum erythropoietin levels by radioimmunoassay in polycythaemia.
Birgegård G; Miller O; Caro J; Erslev A
Scand J Haematol; 1982 Aug; 29(2):161-7. PubMed ID: 7134888
[TBL] [Abstract][Full Text] [Related]
36. [High hemoglobin, not always polycythaemia vera. Weak evidence for the effect of venesection in other erythrocytoses].
Hultcrantz M; Admasie J; Beshara S; Landin B; Palmblad J
Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2354-7. PubMed ID: 23367550
[No Abstract] [Full Text] [Related]
37. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
38. Polycythemia rubra vera.
Bilgrami S; Greenberg BR
Semin Oncol; 1995 Aug; 22(4):307-26. PubMed ID: 7638629
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.
Najean Y; Schlageter MH; Toubert ME; Podgorniak MP
Nouv Rev Fr Hematol (1978); 1990; 32(4):237-40. PubMed ID: 2290709
[TBL] [Abstract][Full Text] [Related]
40. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
